Mike Mitchell
@mjmitchell_lab
Associate Professor of Bioengineering @pennbioeng | Lipid Nanoparticles (LNPs) | mRNA Therapeutics & Vaccines | Drug Delivery | Biomaterials | Immunotherapy
ID: 349089944
https://mitchell-lab.seas.upenn.edu 05-08-2011 14:43:58
2,2K Tweet
6,6K Takipçi
670 Takip Edilen
The #PennBioengineering seminar series returns in two weeks with Pranam Chatterjee speaking about “Designing Programmable Protein Therapeutics with Generative Language Models." Thursday, September 5th at 3:30 PM Abstract & bio: bit.ly/4dTHrXs
Very much looking forward to the next coming days, full of amazing talks and networking with participants around the world @ #Nanomedicine Symposium @ September 3–5, 2024, Rüdesheim, Germany. Have a pick to the line-up of speakers in here: beilstein-institut.de/en/symposia/na… Beilstein-Institut [email protected]
André Nel UCLA and Mike Mitchell Penn Engineering presented their works on #LipidNanoparticles for #mRNA delivery in different biological contexts. #BeilsteinNanomedicine2024
Thrilled to share our latest in Nature Materials led by Postdoc Ningqiang Gong (now Prof USTC Global) showing that tumor extracellular vesicles act as a biological barrier to nanoparticle delivery to solid tumors! Free access: rdcu.be/dSHt2 penntoday.upenn.edu/news/tumor-def…
Fun times on the chairlift with Roy van der Meel! Great catching up with the Controlled Release Society crew Avi Schroeder Dan Peer Twan Lammers at the Beilstein Institute Nanomedicine Symposium in Rüdesheim am Rhein Germany, thanks Santos' Lab and Wolfgang Parak for the invite!
Understanding how solid tumors resist treatment is key in the fight against cancer. Mike Mitchell is exploring tumors' “security system” to weaken their defenses, as published in Nature Materials. Read more: bit.ly/4dRz27l
